Conjunctivitis in adult patients with moderate‐to‐severe atopic dermatitis: results from five tralokinumab clinical trials
British Journal of Dermatology2021Vol. 186(3), pp. 453–465
Citations Over TimeTop 1% of 2021 papers
Andreas Wollenberg, Lisa A. Beck, Marjolein de Bruin‐Weller, Eric L. Simpson, Shinichi Imafuku, Mark Boguniewicz, Rebecca Zachariae, C.K. Olsen, Jacob P. Thyssen
Abstract
Treatment with tralokinumab was associated with an increased incidence of conjunctivitis vs. placebo, but these cases were mostly mild and transient.
Related Papers
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)